{"organizations": [], "uuid": "bc22c87d102ab6bdb18f3ba7b6bd71122262ac46", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-clovis-oncology-receives-positive/brief-clovis-oncology-receives-positive-trend-vote-in-european-regulatory-review-ovarian-cancer-treatment-idUSASM000JKO", "country": "US", "domain_rank": 408, "title": "BRIEF-Clovis Oncology Receives Positive Trend Vote In European Regulatory Review Ovarian Cancer Treatment", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.1, "site_type": "news", "published": "2018-02-22T06:20:00.000+02:00", "replies_count": 0, "uuid": "bc22c87d102ab6bdb18f3ba7b6bd71122262ac46"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-clovis-oncology-receives-positive/brief-clovis-oncology-receives-positive-trend-vote-in-european-regulatory-review-ovarian-cancer-treatment-idUSASM000JKO", "ord_in_thread": 0, "title": "BRIEF-Clovis Oncology Receives Positive Trend Vote In European Regulatory Review Ovarian Cancer Treatment", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - clovis oncology inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 21 (Reuters) - Clovis Oncology Inc:\n* CLOVIS ONCOLOGY RECEIVES POSITIVE TREND VOTE FROM CHMP IN EUROPEAN REGULATORY REVIEW FOR RUCAPARIB OVARIAN CANCER TREATMENT INDICATION\n* CLOVIS ONCOLOGY INC - PENDING A POSITIVE RECOMMENDATION BY CHMP FOR RUCAPARIB TABLETS, FINAL APPROVAL BY EUROPEAN COMMISSION WOULD FOLLOW IN Q2 2018 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-22T06:20:00.000+02:00", "crawled": "2018-02-22T17:48:09.000+02:00", "highlightTitle": ""}